A detailed history of Franklin Resources Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Franklin Resources Inc holds 1,196,059 shares of EW stock, worth $81 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,196,059
Previous 1,168,866 2.33%
Holding current value
$81 Million
Previous $108 Million 26.9%
% of portfolio
0.02%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$59.7 - $93.78 $1.62 Million - $2.55 Million
27,193 Added 2.33%
1,196,059 $78.9 Million
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $1.4 Million - $1.56 Million
-16,555 Reduced 1.4%
1,168,866 $108 Million
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $4.26 Million - $5.61 Million
58,749 Added 5.21%
1,185,421 $113 Million
Q4 2023

Feb 09, 2024

SELL
$61.71 - $77.76 $10.5 Million - $13.2 Million
-170,150 Reduced 13.12%
1,126,672 $85.9 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $31.8 Million - $42.8 Million
-458,565 Reduced 26.12%
1,296,822 $89.8 Million
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $2.57 Million - $2.97 Million
-31,521 Reduced 1.76%
1,755,387 $166 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $59.9 Million - $68.2 Million
-807,106 Reduced 31.11%
1,786,908 $148 Million
Q4 2022

Feb 10, 2023

SELL
$68.3 - $87.44 $75.4 Million - $96.5 Million
-1,104,141 Reduced 29.86%
2,594,014 $194 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $14.6 Million - $19 Million
-177,113 Reduced 4.57%
3,698,155 $306 Million
Q2 2022

Aug 11, 2022

SELL
$86.5 - $128.27 $32.4 Million - $48 Million
-374,035 Reduced 8.8%
3,875,268 $368 Million
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $8.21 Million - $10.3 Million
80,476 Added 1.93%
4,249,303 $500 Million
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $11.4 Million - $14 Million
107,260 Added 2.64%
4,168,827 $540 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $5.49 Million - $6.55 Million
53,357 Added 1.33%
4,061,567 $460 Million
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $241,375 - $301,604
2,879 Added 0.07%
4,008,210 $415 Million
Q1 2021

May 13, 2021

SELL
$78.68 - $90.67 $16.3 Million - $18.7 Million
-206,543 Reduced 4.9%
4,005,331 $335 Million
Q4 2020

Feb 10, 2021

SELL
$71.69 - $91.23 $14.1 Million - $18 Million
-196,927 Reduced 4.47%
4,211,874 $384 Million
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $3.45 Million - $4.49 Million
-51,370 Reduced 1.15%
4,408,801 $352 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $169 Million - $226 Million
2,941,683 Added 193.72%
4,460,171 $347 Million
Q1 2020

May 13, 2020

SELL
$52.41 - $81.0 $554,759 - $857,385
-10,585 Reduced 0.69%
1,518,488 $286 Million
Q4 2019

Feb 12, 2020

SELL
$71.7 - $82.09 $764,035 - $874,751
-10,656 Reduced 0.69%
1,529,073 $357 Million
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $2.97 Million - $3.64 Million
48,204 Added 3.23%
1,539,729 $339 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $3.1 Million - $3.59 Million
-55,696 Reduced 3.6%
1,491,525 $276 Million
Q1 2019

May 14, 2019

SELL
$47.89 - $64.05 $19.3 Million - $25.8 Million
-402,515 Reduced 20.64%
1,547,221 $296 Million
Q4 2018

Feb 12, 2019

SELL
$46.41 - $56.94 $1.68 Million - $2.06 Million
-36,100 Reduced 1.82%
1,949,736 $299 Million
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $2.6 Million - $3.3 Million
-56,925 Reduced 2.79%
1,985,836 $346 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $20,036 - $24,213
472 Added 0.02%
2,042,761 $297 Million
Q1 2018

May 10, 2018

SELL
$37.19 - $47.45 $6,099 - $7,781
-164 Reduced 0.01%
2,042,289 $285 Million
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $2.83 Million - $3.3 Million
-83,773 Reduced 3.94%
2,042,453 $230 Million
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $77.2 Million - $82.6 Million
2,126,226
2,126,226 $232 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.